Contact UsInvestorsCareersMediaScienceContact Us
HomePartnershipsWorking with the NHS and other Healthcare OrganisationsDonations and GrantsDonations of Goods, Services and Benefit in KindBreast Cancer Service Audit and Projection ToolkitBreast Cancer Service Audit and Projection ToolkitSupporting healthcare professionals to deliver efficient, high-quality breast cancer care.

Breast cancer is the most common form of cancer in the United Kingdom (UK) and its incidence has increased over the past two decades.1,2 In parallel with rising patient numbers, the rate at which UK cancer waiting time targets are being met has consistently fallen since 2009.3 Furthermore, the average number of new cases of breast cancer in females annually is projected to continue to rise from approximately 61,800 cases in 2023-2025 to approximately 69,900 cases in 2038-2040.2 The increasing demand on cancer services, compounded by the lasting impact of the COVID-19 pandemic, is a significant challenge faced by the National Health Service (NHS).4,5 In order to address such challenges, auditing of cancer services and informed workforce and service planning have been highlighted as essential for the delivery of efficient high-quality care.4,5,6

To support NHS breast cancer services, Pfizer, in collaboration with J&D forecasting and three clinical oncologists, have developed a breast cancer service audit and projection toolkit. The toolkit is designed to support NHS trusts to audit their breast cancer services and use this data to inform current and future service planning and improve patient care. Local data, including staffing numbers and composition, numbers of clinics and patients, stage of breast cancer (early vs metastatic), therapy types, average therapy durations and progression rates, can be used to generate personalised projections of service demand. In turn, the toolkit can analyse this data and propose the number of clinics and specific staff required to deliver this service, and the associated financial cost.

The breast cancer service audit and projection toolkit will consist of:

All NHS hospital trusts within the UK are eligible to apply for this service donation. There is no limit to the number of trusts to which the toolkit can be provided.

It is important to note that Pfizer will not have access to, nor will Pfizer be privy to, any data collected. Patient confidentiality will be strictly maintained. The toolkit will be downloaded by a member of staff at the respective NHS trust and the toolkit should always kept on an NHS trust computer. No data will be removed from the hospital and once downloaded, the toolkit will remain under the NHS trust’s possession.

Apply for the Breast Cancer Service Audit and Projection Toolkit


  1. NHS England. Cancer Registration Statistics, England 2020. Published October 2022.
  2. Cancer Research UK. Breast cancer incidence (invasive) statistics. Accessed January 2024.
  3. NHS England. Cancer waiting times. Accessed Januray 2024.
  4. NHS England. NHS Long term workforce plan. Published June 2023.
  5. Aggarwal, A., et al. The future of cancer care in the UK - time for a radical and sustainable National Cancer Plan. Published November 2023.
  6. Aggarwal A, Lievens Y, Sullivan R, Nolte E. What Really Matters for Cancer Care - Health Systems Strengthening or Technological Innovation? Published July 2022.
PP-UNP-GBR-8477 / March 2024
Science Products Responsibility PartnershipsCareers Privacy Statement Terms of Use Contact UsSitemap Copyright © 2017-2024 Pfizer Limited. PP-UNP-GBR-8108 / January 2024. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427. This website is intended for the general public in the UK.